Induction of apoptosis and G2/M arrest by N-methyl-N′-nitro-N- nitrosoguanidine in human prostate carcinoma cells

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 563, Issue 2, 2004, Pages 139-149

  Park, Cheol ^a,b   Choi, Byung Tae ^a   Cheong, JaeHun ^b   Moon, Sung Kwon ^c   Kim, Cheorl Ho ^d   Lee, Won Ho ^b   Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

^b Pusan National University   (South Korea)

^c Chungju National University   (South Korea)

^d Dongguk University   (South Korea)

Author keywords

Apoptosis; G2 M arrest; MNNG; p21 WAF1 CIP1

Indexed keywords

CYCLIN DEPENDENT KINASE 2; METHYLNITRONITROSOGUANIDINE; PROTEIN KINASE; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPORTER GENE; UPREGULATION;

APOPTOSIS; CDC2 PROTEIN KINASE; CELL DIVISION; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; G2 PHASE; HUMANS; MALE; METHYLNITRONITROSOGUANIDINE; MITOSIS; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 4444242675     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2004.06.007     Document Type: Article

References (46)

1. C.J. Sherr Cancer cell cycles Science 1996 274
2. C.J. Sherr, and J.M. Roberts Inhibitors of mammalian G1 cyclin-dependent kinases Genes Dev. 9 1995 1149 1163
3. R.W. King, P.K. Jackson, and M.W. Kirschner Mitosis in transition Cell 79 1994 563 571
4. T.M. Guadagno, M. Ohtsubo, J.M. Roberts, and R.K. Assoian A link between cyclin A expression and adhesion-dependent cell cycle progression Science 262 1993 1572 1575
5. F. Girard, U. Strausfeld, A. Fernandez, and N.J.C. Lamb Cyclin A is required for the onset of DNA replication in mammalian fibroblasts Cell 67 1991 1169 1179
6. Cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites EMBO J. 10 1991 305 316
7. M.H. Lee, and H.Y. Yang Negative regulators of cyclin-dependent kinases and their roles in cancers Cell. Mol. Life Sci. 58 2001 1907 1922
8. W. Kreis Current chemotherapy and future directions in research for the treatment of advanced hormone-refractory prostate cancer Cancer Invest. 13 1995 296 312
9. A.G. Hall, and M.J. Tilby Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies Blood Rev. 6 1992 163 173
10. K. Wassermann Intragenomic heterogeneity of DNA damage formation and repair: a review of cellular responses to covalent drug DNA interaction Crit. Rev. Toxicol. 24 1994 281 322
11. A. Kat, W.G. Thilly, W.H. Fang, M.J. Longley, G.M. Li, and P. Modrich An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair Proc. Natl. Acad. Sci. U.S.A. 90 1993 6424 6428
12. J.M. Carethers, M.T. Hawn, D.P. Chauhan, M.C. Luce, G. Marra, M. Koi, and C.R. Boland Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N′-nitro-N-nitrosoguanidine J. Clin. Invest. 98 1996 199 206
13. P. Cejka, L. Stojic, N. Mojas, A.M. Russell, K. Heinimann, E. Cannavo, M. di Pietro, G. Marra, and J. Jiricny Methylation-induced G(2)/M arrest requires a full complement of the mismatch repair protein hMLH1 EMBO J. 22 2003 2245 2254
14. M.Z. Fang, M.H. Lee, Y.S. Lee, Y.C. Kim, B.M. Lee, and M.H. Cho Low expression of cyclin D2 in G2/M-arrested and transformed proliferating Balb/3T3 cells J. Vet. Med. Sci. 64 2002 201 205
15. M.Z. Fang, W.C. Mar, and M.H. Cho Cell cycle was disturbed in the MNNG-induced initiation stage during in vitro two-stage transformation of Balb/3T3 cells Toxicology 163 2001 175 184
16. L.J. Rasmussen, M. Rasmussen, A. Lutzen, H.C. Bisgaard, and K.K. Singh The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents Exp. Cell Res. 257 2000 127 134
17. Q.A. Khan, and A. Dipple Diverse chemical carcinogens fail to induce G(1) arrest in MCF-7 cells Carcinogenesis 21 2000 1611 1618
18. M. Savio, L.A. Stivala, L. Bianchi, V. Vannini, and E. Prosperi Involvement of the proliferating cell nuclear antigen (PCNA) in DNA repair induced by alkylating agents and oxidative damage in human fibroblasts Carcinogenesis 19 1998 591 596
19. M.T. Hawn, A. Umar, J.M. Carethers, G. Marra, T.A. Kunkel, C.R. Boland, and M. Koi Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint Cancer Res. 55 1995 3721 3725
20. A.W. Adamson, W.J. Kim, S. Shangary, R. Baskaran, and K.D. Brown ATM is activated in response to N-methyl-N′-nitro-N-nitrosoguanidine-induced DNA alkylation J. Biol. Chem. 277 2002 38222 38229
21. D.R. Duckett, S.M. Bronstein, Y. Taya, Modrich, and K.D. P. hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage Proc. Natl. Acad. Sci. U.S.A. 96 1996 12384 12388
22. M.J. Hickman, and L.D. Samson Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents Proc. Natl. Acad. Sci. U.S.A. 96 1999 10764 10769
23. A.S. Jaiswal, and S. Narayan SN2 DNA-alkylating agent-induced phosphorylation of p53 and activation of p21 gene expression Mutat. Res. 500 2002 17 30
24. Y.H. Choi, S.J. Lee, P. Nguyen, J.S. Jang, J. Lee, M.L. Wu, E. Takano, M. Maki, P.A. Henkart, and J.B. Trepel Regulation of cyclin D1 by calpain protease J. Biol. Chem. 272 1997 28479 28484
25. Y.H. Choi, W.H. Lee, K.Y. Park, and L. Zhang p53-independent induction of p21(WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells Jpn. J. Cancer Res. 91 2000 164 173
26. W.B. Isaacs, B.S. Carter, and C.M. Ewing Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles Cancer Res. 51 1991 4716 4720
27. S.J. Rubin, D.E. Hallahan, C.R. Ashman, D.G. Brachman, M.A. Beckett, S. Virudachalam, D.W. Yandell, and R.R. Weichselbaum Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes J. Surg. Oncol. 46 1991 31 36
28. Y. Tominaga, T. Tsuzuki, A. Shiraishi, H. Kwate, and M. Sekiguchi Alkylation-induced apoptosis of embryonic stem cells in which the gene for DNA-repair, methyltransferase, had been disrupted by gene targeting Carcinogenesis 18 1997 889 896
29. S. Edara, S. Kanugula, and A.E. Pegg Expression of the inactive C145A mutant human O6-alkylguanine-DNA alkyltransferase in E. coli increases cell killing and mutations by N-methyl-N′-nitro-N-nitrosoguanidine Carcinogenesis 20 1999 103 108
30. T.C. Hour, S.Y. Shiau, and J.K. Lin Suppression of N-methyl-N′- nitro-N-nitrosoguanidine- and S-nitrosoglutathione-induced apoptosis by Bcl-2 through inhibiting glutathione-S-transferase pi in NIH3T3 cells Toxicol. Lett. 110 1999 191 202
31. A. Lützen, H.C. Bisgaard, and L.J. Rasmussen Cyclin D1 expression and cell cycle response in DNA mismatch repair-deficient cells upon methylation and UV-C damage Exp. Cell Res. 292 2004 123 134
32. C.C. Yeh, C. Lee, and R. Dahiya DNA mismatch repair enzyme activity and gene expression in prostate cancer Biochem. Biophys. Res. Commun. 285 2001 409 413
33. S.J. Elledges, and J.W. Harper Cdk inhibitor: on the threshold of checkpoints and development Curr. Opin. Cell Biol. 6 1994 847 852
34. Y.H. Ling, A.K. el-Naggar, W. Priebe, and R. Perez-Soler Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells Mol. Pharmacol. 49 1996 832 841
35. R.B. Lock, and W.E. Ross Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells Cancer Res. 50 1990 3761 3766
36. R.J. Sleiman, D.R. Catchpoole, and B.W. Stewart Drug-induced death of leukaemic cells after G2/M arrest: higher order DNA fragmentation as an indicator of mechanism Br. J. Cancer 77 1998 40 50
37. K. Ohsumi, C. Katagiri, and T. Kishimoto Chromosome condensation in Xenopus mitotic extracts without histone H1 Science 262 1993 2033 2035
38. W.S. el-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
39. T. Waldman, K.W. Kinzler, and B. Vogelstain p21 is necessary for the p53-mediated G1 arrest in human cancer cells Cancer Res. 55 1995 5187 5190
40. Y. Xiong, G. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach p21 is a universal inhibitor of cyclin kinases Nature 366 1993 701 704
41. M.L. Agarwal, A. Agarwal, W.R. Taylor, and G.R. Stark p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts Proc. Natl. Acad. Sci. U.S.A. 92 1995 8493 8497
42. WAF1/CIP1/SDI1 protein in phorbol ester-induced G2/M arrest J. Biol. Chem. 271 1996 29556 29560
43. Cip1 at the onset of mitosis: a role at the G2/M-phase transition Mol. Cell. Biol. 18 1998 546 557
44. M.B. Datto, Y. Yu, and X.F. Wang Functional analysis of the transforming growth factor β responsive elements in the WAF/Cip1/p21 promoter J. Biol. Chem. 270 1995 28623 28628
45. WAF1/CIP1 expression by p53-independent pathways Oncogene 12 1996 1557 1564
46. A. Vogt, J. Sun, Y. Qian, A.D. Hamilton, and S.M. Sebti The geranylgeranyltransferase-I inhibitor GGTI-298 arrests human tumor cells in G0/G1 and induces p21(WAF1/CIP1/SDI1) in a p53-independent manner J. Biol. Chem. 272 1997 27224 27229